Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers.
Saved in:
| Title: | Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers. |
|---|---|
| Authors: | Eichholz K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Fukazawa Y; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA., Peterson CW; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and., Haeseleer F; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and.; Department of Medicine, University of Washington, Seattle, Washington, USA., Medina M; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA., Hoffmeister S; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA., Duell DM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA., Varco-Merth BD; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA., Dross S; Washington National Primate Research Center (WaNPRC), Seattle, Washington, USA.; Department of Microbiology, University of Washington, Seattle, Washington, USA., Park H; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA., Labriola CS; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA., Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA., Murnane RD; Washington National Primate Research Center (WaNPRC), Seattle, Washington, USA., Smedley JV; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA., Jin L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Gong J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Rust BJ; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Fuller DH; Washington National Primate Research Center (WaNPRC), Seattle, Washington, USA.; Department of Microbiology, University of Washington, Seattle, Washington, USA., Kiem HP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA., Okoye AA; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and.; Department of Medicine, University of Washington, Seattle, Washington, USA. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2024 Apr 01; Vol. 134 (7). Date of Electronic Publication: 2024 Apr 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38557496 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Eichholz+K%22">Eichholz K</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Fukazawa+Y%22">Fukazawa Y</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Peterson+CW%22">Peterson CW</searchLink>; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and.<br /><searchLink fieldCode="AU" term="%22Haeseleer+F%22">Haeseleer F</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and.; Department of Medicine, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Medina+M%22">Medina M</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Hoffmeister+S%22">Hoffmeister S</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Duell+DM%22">Duell DM</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Varco-Merth+BD%22">Varco-Merth BD</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Dross+S%22">Dross S</searchLink>; Washington National Primate Research Center (WaNPRC), Seattle, Washington, USA.; Department of Microbiology, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Park+H%22">Park H</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Labriola+CS%22">Labriola CS</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Axthelm+MK%22">Axthelm MK</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Murnane+RD%22">Murnane RD</searchLink>; Washington National Primate Research Center (WaNPRC), Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Smedley+JV%22">Smedley JV</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Jin+L%22">Jin L</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Gong+J%22">Gong J</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Rust+BJ%22">Rust BJ</searchLink>; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Fuller+DH%22">Fuller DH</searchLink>; Washington National Primate Research Center (WaNPRC), Seattle, Washington, USA.; Department of Microbiology, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Kiem+HP%22">Kiem HP</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Picker+LJ%22">Picker LJ</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Okoye+AA%22">Okoye AA</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Corey+L%22">Corey L</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and.; Department of Medicine, University of Washington, Seattle, Washington, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2024 Apr 01; Vol. 134 (7). <i>Date of Electronic Publication: </i>2024 Apr 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38557496 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI169309 Languages: – Code: eng Text: English Titles: – TitleFull: Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Eichholz K – PersonEntity: Name: NameFull: Fukazawa Y – PersonEntity: Name: NameFull: Peterson CW – PersonEntity: Name: NameFull: Haeseleer F – PersonEntity: Name: NameFull: Medina M – PersonEntity: Name: NameFull: Hoffmeister S – PersonEntity: Name: NameFull: Duell DM – PersonEntity: Name: NameFull: Varco-Merth BD – PersonEntity: Name: NameFull: Dross S – PersonEntity: Name: NameFull: Park H – PersonEntity: Name: NameFull: Labriola CS – PersonEntity: Name: NameFull: Axthelm MK – PersonEntity: Name: NameFull: Murnane RD – PersonEntity: Name: NameFull: Smedley JV – PersonEntity: Name: NameFull: Jin L – PersonEntity: Name: NameFull: Gong J – PersonEntity: Name: NameFull: Rust BJ – PersonEntity: Name: NameFull: Fuller DH – PersonEntity: Name: NameFull: Kiem HP – PersonEntity: Name: NameFull: Picker LJ – PersonEntity: Name: NameFull: Okoye AA – PersonEntity: Name: NameFull: Corey L IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2024 Apr 01 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1558-8238 Numbering: – Type: volume Value: 134 – Type: issue Value: 7 Titles: – TitleFull: The Journal of clinical investigation Type: main |
| ResultId | 1 |